Nalaganje...
Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function
PURPOSE: Revefenacin, a long-acting muscarinic antagonist for nebulization, has been shown to improve lung function in patients with chronic obstructive pulmonary disease. Here we report pharmacokinetic (PK) and safety results from two multicenter, open-label, single-dose trials evaluating revefenac...
Shranjeno v:
| izdano v: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790214/ https://ncbi.nlm.nih.gov/pubmed/31632000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S203709 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|